RADAY GILEAD (Chief Operating Officer) sold 6.1% of their position (14.13M shares) of REDHILL BIOPHARMA LTD. on the open market
Open‑market sale worth $1.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/13/2026ACC: 0001178913-26-003473
Officer· Chief Operating Officer
Since Mar 2026
+14.02M
Net shares
Net buyer
$1.4K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
28.15M acquired · 14.13M disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−14.13M
Price / share
$0.00
Trade value
$1.41K
% of position
6.1%
7/10/2026
232.91M→218.78M
Total
Net shares
−14.13M
Net value
-$1.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 7/10/2026 | S · Sale | −14.13M | $0.00 | $1.41K | 6.1% | 232.91M | 218.78M |
| Total | −14.13M | -$1.41K | ||||||
Derivative Transactions1
American Depositary Shares
Direct
Converts to
Ordinary Shares
28.15M shares
Shares
+28.15M
Strike price
Held after
104.13M
Exercisable
—
7/10/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| American Depositary Shares Direct | Ordinary Shares28.15M shares | 7/10/2026 | M · Option Exercise | +28.15M | — | 104.13M |